Autism

The Lancet

Volumn 383, Issue 9920, 2014, Pages 896-910

  Lai, Meng Chuan ^a,b   Lombardo, Michael V ^a,c   Baron Cohen, Simon ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CYPRUS   (Cyprus)

^d CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; ANXIETY; AUTISM; BEHAVIOR; COMORBIDITY; CONFERENCE PAPER; EARLY DIAGNOSIS; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; EXECUTIVE DYSFUNCTION; EXECUTIVE FUNCTION; GENE MUTATION; GENETIC RISK; GENETICS; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; NERVE CELL DIFFERENTIATION; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX RATIO; SOCIAL COGNITION; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; NEUROBIOLOGY; OUTCOME ASSESSMENT;

AUTISTIC DISORDER; EARLY DIAGNOSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84896715530     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61539-1     Document Type: Conference Paper

References (175)

1. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943; 2: 217-50.
2. Asperger H. Autistic psychopathy in childhood. In: Frith U, ed. Autism and Asperger syndrome. Cambridge, UK: Cambridge University Press, 1991: 37-92.
3. Rutter M. Diagnosis and definition of childhood autism. J Autism Child Schizophr 1978; 8: 139-61.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing, 2013.
5. Boucher J. Research review: structural language in autistic spectrum disorder - characteristics and causes. J Child Psychol Psychiatry 2012; 53: 219-33.
6. Lai MC, Lombardo MV, Chakrabarti B, Baron-Cohen S. Subgrouping the autism "spectrum": reflections on DSM-5. PLoS Biol 2013; 11: e1001544.
7. Lotter V. Epidemiology of autistic conditions in young children. Soc Psychiatry Psychiatr Epidemiol 1966; 1: 124-35.
8. Fisch GS. Nosology and epidemiology in autism: classification counts. Am J Med Genet C Semin Med Genet 2012; 160C: 91-103.
9. Keyes KM, Susser E, Cheslack-Postava K, Fountain C, Liu K, Bearman PS. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol 2012; 41: 495-503.
10. Elsabbagh M, Divan G, Koh YJ, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5: 160-79.
11. Fombonne E, Quirke S, Hagen A. Epidemiology of pervasive developmental disorders. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 90-111.
12. Mattila ML, Kielinen M, Linna SL, et al. Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study. J Am Acad Child Adolesc Psychiatry 2011; 50: 583-92.
13. Kim YS, Leventhal BL, Koh YJ, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 2011; 168: 904-12.
14. Baron-Cohen S, Scott FJ, Allison C, et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009; 194: 500-09.
15. Hsu S-W, Chiang P-H, Lin L-P, Lin J-D. Disparity in autism spectrum disorder prevalence among Taiwan National Health Insurance enrollees: age, gender and urbanization effects. Res Autism Spectr Disord 2012; 6: 836-41.
16. Idring S, Rai D, Dal H, et al. Autism spectrum disorders in the stockholm youth cohort: design, prevalence and validity. PLoS One 2012; 7: e41280.
17. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged US children: 2007 to 2011-2012. Hyattsville, MD: National Center for Health Statistics, 2013.
18. Russell G, Rodgers LR, Ukoumunne OC, Ford T. Prevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort Study. J Autism Dev Disord 2013; published online May 30. DOI:10.1007/s10803- 013-1849-0.
19. Saemundsen E, Magnusson P, Georgsdottir I, Egilsson E, Rafnsson V. Prevalence of autism spectrum disorders in an Icelandic birth cohort. BMJ Open 2013; 3: e002748.
20. Brugha TS, McManus S, Bankart J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 2011; 68: 459-65.
21. Barger BD, Campbell JM, McDonough JD. Prevalence and onset of regression within autism spectrum disorders: a meta-analytic review. J Autism Dev Disord 2013; 43: 817-28.
22. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol 2011; 9: e1001081.
23. Begeer S, Mandell D, Wijnker-Holmes B, et al. Sex differences in the timing of identification among children and adults with autism spectrum disorders. J Autism Dev Disord 2013; 43: 1151-56.
24. Giarelli E, Wiggins LD, Rice CE, et al. Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil Health J 2010; 3: 107-16.
25. Russell G, Steer C, Golding J. Social and demographic factors that influence the diagnosis of autistic spectrum disorders. Soc Psychiatry Psychiatr Epidemiol 2011; 46: 1283-93.
26. Dworzynski K, Ronald A, Bolton P, Happe F. How different are girls and boys above and below the diagnostic threshold for autism spectrum disorders? J Am Acad Child Adolesc Psychiatry 2012; 51: 788-97.
27. Kopp S, Gillberg C. The Autism Spectrum Screening Questionnaire (ASSQ)-revised extended version (ASSQ-REV): an instrument for better capturing the autism phenotype in girls? A preliminary study involving 191 clinical cases and community controls. Res Dev Disabil 2011; 32: 2875-88.
28. Cheslack-Postava K, Jordan-Young RM. Autism spectrum disorders: toward a gendered embodiment model. Soc Sci Med 2012; 74: 1667-74.
29. Lai MC, Lombardo MV, Pasco G, et al. A behavioral comparison of male and female adults with high functioning autism spectrum conditions. PLoS One 2011; 6: e20835.
30. Robinson EB, Lichtenstein P, Anckarsater H, Happe F, Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci USA 2013; 110: 5258-62.
31. Werling DM, Geschwind DH. Sex differences in autism spectrum disorders. Curr Opin Neurol 2013; 26: 146-53.
32. Rodier PM. Environmental exposures that increase the risk of autism spectrum disorders. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 863-74.
33. Corrales MA, Herbert M. Autism and environmental genomics: synergistic systems approaches to autism complexity. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 875-92.
34. Sandin S, Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2012; 51: 477-86.
35. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry 2011; 16: 1203-12.
36. Lampi KM, Hinkka-Yli-Salomaki S, Lehti V, et al. Parental age and risk of autism spectrum disorders in a Finnish national birth cohort. J Autism Dev Disord 2013; published online March 12. DOI:10.1007/s10803-013-1801-3.
37. Michaelson JJ, Shi Y, Gujral M, et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 2012; 151: 1431-42.
38. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of fathers age to disease risk. Nature 2012; 488: 471-75.
39. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242-45.
40. ORoak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-50.
41. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237-41.
42. Sucksmith E, Roth I, Hoekstra RA. Autistic traits below the clinical threshold: re-examining the broader autism phenotype in the 21st century. Neuropsychol Rev 2011; 21: 360-89.
43. Roelfsema MT, Hoekstra RA, Allison C, et al. Are autism spectrum conditions more prevalent in an information-technology region? A school-based study of three regions in the Netherlands. J Autism Dev Disord 2012; 42: 734-39.
44. Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2013; published online Jan 22. DOI:10.1038/mp.2012.197.
45. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009; 195: 7-14.
46. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 2013; 70: 71-77.
47. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, WolffC. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007; 115: 1482-89.
48. Christensen J, Gronborg TK, Sorensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696-703.
49. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346: f2059.
50. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011; 128: 344-55.
51. Suren P, Roth C, Bresnahan M, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 2013; 309: 570-77.
52. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347: 1477-82.
53. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosalcontaining vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004; 114: 793-804.
54. DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. J Pediatr 2013; published online March 29. DOI:10.1016/j.jpeds.2013.02.001.
55. SimonoffE, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 921-29.
56. Hofvander B, Delorme R, Chaste P, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry 2009; 9: 35.
57. Lugnegard T, Hallerback MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil 2011; 32: 1910-17.
58. Mattila ML, Hurtig T, Haapsamo H, et al. Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study. J Autism Dev Disord 2010; 40: 1080-93.
59. Lugnegard T, Hallerback MU, Gillberg C. Personality disorders and autism spectrum disorders: what are the connections? Compr Psychiatry 2012; 53: 333-40.
60. Joshi G, Wozniak J, Petty C, et al. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord 2013; 43: 1314-25.
61. Kohane IS, McMurry A, Weber G, et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 2012; 7: e33224.
62. SimonoffE, Jones CR, Baird G, Pickles A, Happe F, Charman T. The persistence and stability of psychiatric problems in adolescents with autism spectrum disorders. J Child Psychol Psychiatry 2013; 54: 186-94.
63. Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams K. A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality. Dev Med Child Neurol 2012; 54: 306-12.
64. Bilder D, Botts EL, Smith KR, et al. Excess mortality and causes of death in autism spectrum disorders: a follow up of the 1980s Utah/UCLA autism epidemiologic study. J Autism Dev Disord 2013; 43: 1196-204.
65. Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry 2004; 45: 212-29.
66. Billstedt E, Gillberg C, Gillberg C. Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord 2005; 35: 351-60.
67. Howlin P, Moss P, Savage S, Rutter M. Social outcomes in mid- to later adulthood among individuals diagnosed with autism and average nonverbal IQ as children. J Am Acad Child Adolesc Psychiatry 2013; 52: 572-81.
68. Farley MA, McMahon WM, Fombonne E, et al. Twenty-year outcome for individuals with autism and average or near-average cognitive abilities. Autism Res 2009; 2: 109-18.
69. Fountain C, Winter AS, Bearman PS. Six developmental trajectories characterize children with autism. Pediatrics 2012; 129: e1112-20.
70. Gotham K, Pickles A, Lord C. Trajectories of autism severity in children using standardized ADOS scores. Pediatrics 2012; 130: e1278-84.
71. Landa RJ, Gross AL, Stuart EA, Bauman M. Latent class analysis of early developmental trajectory in baby siblings of children with autism. J Child Psychol Psychiatry 2012; 53: 986-96.
72. Fein D, Barton M, Eigsti IM, et al. Optimal outcome in individuals with a history of autism. J Child Psychol Psychiatry 2013; 54: 195-205.
73. Taylor JL, Seltzer MM. Changes in the autism behavioral phenotype during the transition to adulthood. J Autism Dev Disord 2010; 40: 1431-46.
74. Pilling S, Baron-Cohen S, Megnin-Viggars O, Lee R, Taylor C. Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance. BMJ 2012; 344: e4082.
75. Shattuck PT, Narendorf SC, Cooper B, Sterzing PR, Wagner M, Taylor JL. Postsecondary education and employment among youth with an autism spectrum disorder. Pediatrics 2012; 129: 1042-49.
76. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatry 2012; 57: 275-83.
77. Happe F, Charlton RA. Aging in autism spectrum disorders: a mini-review. Gerontology 2012; 58: 70-78.
78. Elsabbagh M, Johnson MH. Getting answers from babies about autism. Trends Cogn Sci 2010; 14: 81-87.
79. Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009; 123: 1383-91.
80. Mandell DS, Novak MM, Zubritsky CD. Factors associated with age of diagnosis among children with autism spectrum disorders. Pediatrics 2005; 116: 1480-86.
81. Charman T, Gotham K. Measurement issues: screening and diagnostic instruments for autism spectrum disorders - lessons from research and practice. Child Adolesc Ment Health 2013; 18: 52-63.
82. Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120: 1183-215.
83. Al-Qabandi M, Gorter JW, Rosenbaum P. Early autism detection: are we ready for routine screening? Pediatrics 2011; 128: e211-17.
84. OzonoffS, Iosif AM, Baguio F, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry 2010; 49: 256-66.
85. Chawarska K, Macari S, Shic F. Decreased spontaneous attention to social scenes in 6-month-old infants later diagnosed with autism spectrum disorders. Biol Psychiatry 2013; 74: 195-203.
86. Wan MW, Green J, Elsabbagh M, Johnson M, Charman T, Plummer F. Quality of interaction between at-risk infants and caregiver at 12-15 months is associated with 3-year autism outcome. J Child Psychol Psychiatry 2013; 54: 763-71.
87. Elison JT, Paterson SJ, WolffJJ, et al. White matter microstructure and atypical visual orienting in 7-month-olds at risk for autism. Am J Psychiatry 2013; published online March 20. DOI:10.1176/appi.ajp.2012.12091150.
88. Elsabbagh M, Fernandes J, Jane Webb S, Dawson G, Charman T, Johnson MH. Disengagement of visual attention in infancy is associated with emerging autism in toddlerhood. Biol Psychiatry 2013; 74: 189-94.
89. Elsabbagh M, Mercure E, Hudry K, et al. Infant neural sensitivity to dynamic eye gaze is associated with later emerging autism. Curr Biol 2012; 22: 338-42.
90. WolffJJ, Gu H, Gerig G, et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry 2012; 169: 589-600.
91. Messinger D, Young GS, OzonoffS, et al. Beyond autism: a baby siblings research consortium study of high-risk children at three years of age. J Am Acad Child Adolesc Psychiatry 2013; 52: 300-08.
92. Ozonoff S, Goodlin-Jones BL, Solomon M. Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol 2005; 34: 523-40.
93. Coleman M, Gillberg C. The autisms, 4th edn. New York, NY: Oxford University Press, 2012.
94. Heil KM, Schaaf CP. The genetics of autism spectrum disorders - a guide for clinicians. Curr Psychiatry Rep 2013; 15: 334.
95. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-64.
96. Rimland B. Infantile autism: the syndrome and its implications for a neural theory of behavior. New York, NY: Appleton-Century-Crofts, 1964.
97. Frith U. Why we need cognitive explanations of autism. Q J Exp Psychol (Hove) 2012; 65: 2073-92.
98. Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a "theory of mind"? Cognition 1985; 21: 37-46.
99. Boucher J. Putting theory of mind in its place: psychological explanations of the socio-emotional-communicative impairments in autistic spectrum disorder. Autism 2012; 16: 226-46.
100. Pelphrey KA, Shultz S, Hudac CM, Vander Wyk BC. Research review: constraining heterogeneity: the social brain and its development in autism spectrum disorder. J Child Psychol Psychiatry 2011; 52: 631-44.
101. Happe FG. The role of age and verbal ability in the theory of mind task performance of subjects with autism. Child Dev 1995; 66: 843-55.
102. Senju A. Spontaneous theory of mind and its absence in autism spectrum disorders. Neuroscientist 2011; 18: 108-13.
103. Chung YS, Barch D, Strube M. A meta-analysis of mentalizing impairments in adults with schizophrenia and autism spectrum disorder. Schizophr Bull 2013; published online May 17. DOI:10.1093/schbul/sbt048.
104. Apperly IA. What is "theory of mind"? Concepts, cognitive processes and individual differences. Q J Exp Psychol (Hove) 2012; 65: 825-39.
105. Lombardo MV, Baron-Cohen S. Unraveling the paradox of the autistic self. Wiley Interdiscip Rev Cogn Sci 2010; 1: 393-403.
106. Lombardo MV, Chakrabarti B, Bullmore ET, et al. Atypical neural self-representation in autism. Brain 2010; 133: 611-24.
107. Dichter GS. Functional magnetic resonance imaging of autism spectrum disorders. Dialogues Clin Neurosci 2012; 14: 319-51.
108. Philip RC, Dauvermann MR, Whalley HC, Baynham K, Lawrie SM, Stanfield AC. A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci Biobehav Rev 2012; 36: 901-42.
109. Hamilton AF. Reflecting on the mirror neuron system in autism: a systematic review of current theories. Dev Cogn Neurosci 2013; 3: 91-105.
110. Geurts HM, Corbett B, Solomon M. The paradox of cognitive flexibility in autism. Trends Cogn Sci 2009; 13: 74-82.
111. White SJ. The triple I hypothesis: taking another(s) perspective on executive dysfunction in autism. J Autism Dev Disord 2013; 43: 114-21.
112. Johnson MH. Executive function and developmental disorders: the flip side of the coin. Trends Cogn Sci 2012; 16: 454-57.
113. Baron-Cohen S, Ashwin E, Ashwin C, Tavassoli T, Chakrabarti B. Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos Trans R Soc Lond B Biol Sci 2009; 364: 1377-83.
114. Mottron L, Bouvet L, Bonnel A, et al. Veridical mapping in the development of exceptional autistic abilities. Neurosci Biobehav Rev 2013; 37: 209-28.
115. Happe F, Frith U. The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord 2006; 36: 5-25.
116. Samson F, Mottron L, Soulieres I, Zeffiro TA. Enhanced visual functioning in autism: an ALE meta-analysis. Hum Brain Mapp 2012; 33: 1553-81.
117. Minshew NJ, Keller TA. The nature of brain dysfunction in autism: functional brain imaging studies. Curr Opin Neurol 2010; 23: 124-30.
118. Ohnishi T, Matsuda H, Hashimoto T, et al. Abnormal regional cerebral blood flow in childhood autism. Brain 2000; 123: 1838-44.
119. Baruth JM, Wall CA, Patterson MC, Port JD. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. Autism Res 2013; published online Feb 21. DOI:10.1002/aur.1273.
120. Vissers ME, Cohen MX, Geurts HM. Brain connectivity and high functioning autism: a promising path of research that needs refined models, methodological convergence, and stronger behavioral links. Neurosci Biobehav Rev 2012; 36: 604-25.
121. Travers BG, Adluru N, Ennis C, et al. Diffusion tensor imaging in autism spectrum disorder: a review. Autism Res 2012; 5: 289-313.
122. Frazier TW, Hardan AY. A meta-analysis of the corpus callosum in autism. Biol Psychiatry 2009; 66: 935-41.
123. Radua J, Via E, Catani M, Mataix-Cols D. Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls. Psychol Med 2011; 41: 1539-50.
124. Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci 2011; 15: 409-16.
125. Just MA, Keller TA, Malave VL, Kana RK, Varma S. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci Biobehav Rev 2012; 36: 1292-313.
126. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and abnormal development of brain connectivity. J Neurosci 2004; 24: 9228-31.
127. Brock J, Brown CC, Boucher J, Rippon G. The temporal binding deficit hypothesis of autism. Dev Psychopathol 2002; 14: 209-24.
128. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2011; 1380: 138-45.
129. Nordahl CW, Scholz R, Yang X, et al. Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. Arch Gen Psychiatry 2012; 69: 53-61.
130. Schumann CM, Hamstra J, Goodlin-Jones BL, et al. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 2004; 24: 6392-401.
131. Nordahl CW, Lange N, Li DD, et al. Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders. Proc Natl Acad Sci USA 2011; 108: 20195-200.
132. Chawarska K, Campbell D, Chen L, Shic F, Klin A, Chang J. Early generalized overgrowth in boys with autism. Arch Gen Psychiatry 2011; 68: 1021-31.
133. Raznahan A, Wallace GL, Antezana L, et al. Compared to what? Early brain overgrowth in autism and the perils of population norms. Biol Psychiatry 2013; published online May 23. DOI:10.1016/j.biopsych.2013.03.022.
134. Via E, Radua J, Cardoner N, Happe F, Mataix-Cols D. Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry 2011; 68: 409-18.
135. Duerden EG, Mak-Fan KM, Taylor MJ, Roberts SW. Regional differences in grey and white matter in children and adults with autism spectrum disorders: an activation likelihood estimate (ALE) meta-analysis. Autism Res 2012; 5: 49-66.
136. Schumann CM, Noctor SC, Amaral DG. Neuropathology of autism spectrum disorders: postmortem studies. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 539-65.
137. Courchesne E, Mouton PR, Calhoun ME, et al. Neuron number and size in prefrontal cortex of children with autism. JAMA 2011; 306: 2001-10.
138. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-84.
139. Casanova MF. Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist 2006; 12: 435-41.
140. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol 2010; 23: 118-23.
141. McAllister AK, van de Water J. Breaking boundaries in neural-immune interactions. Neuron 2009; 64: 9-12.
142. Goines P, Zimmerman A, Ashwood P, Van de Water J. The immune system, autoimmunity, allergy, and autism spectrum disorders. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 395-419.
143. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012; 26: 383-92.
144. Braunschweig D, Van de Water J. Maternal autoantibodies in autism. Arch Neurol 2012; 69: 693-99.
145. Chugani DC. Neurotransmitters. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism spectrum disorders. New York, NY: Oxford University Press, 2011: 566-75.
146. Yamasue H, Yee JR, Hurlemann R, et al. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci 2012; 32: 14109-17.
147. PfaffDW, Rapin I, Goldman S. Male predominance in autism: neuroendocrine influences on arousal and social anxiety. Autism Res 2011; 4: 163-76.
148. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 255-74.
149. Baron-Cohen S. Autism and the technical mind. Sci Am 2012; 307: 72-75.
150. Murdoch JD, State MW. Recent developments in the genetics of autism spectrum disorders. Curr Opin Genet Dev 2013; 23: 310-15.
151. State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 2011; 14: 1499-506.
152. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012; 22: 229-37.
153. Stein JL, Parikshak NN, Geschwind DH. Rare inherited variation in autism: beginning to see the forest and a few trees. Neuron 2013; 77: 209-11.
154. Klei L, Sanders SJ, Murtha MT, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism 2012; 3: 9.
155. Chakrabarti B, Dudbridge F, Kent L, et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009; 2: 157-77.
156. Dawson G, Burner K. Behavioral interventions in children and adolescents with autism spectrum disorder: a review of recent findings. Curr Opin Pediatr 2011; 23: 616-20.
157. Vismara LA, Rogers SJ. Behavioral treatments in autism spectrum disorder: what do we know? Annu Rev Clin Psychol 2010; 6: 447-68.
158. Maglione MA, Gans D, Das L, Timbie J, Kasari C. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics 2012; 130 (suppl 2): S169-78.
159. Callahan K, Shukla-Mehta S, Magee S, Wie M. ABA versus TEACCH: the case for defining and validating comprehensive treatment models in autism. J Autism Dev Disord 2010; 40: 74-88.
160. Smith T, Eikeseth S. O Ivar Lovaas: pioneer of applied behavior analysis and intervention for children with autism. J Autism Dev Disord 2011; 41: 375-8.
161. Reichow B, Barton EE, Boyd BA, Hume K. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012; 10: CD009260.
162. Dawson G, Jones EJ, Merkle K, et al. Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry 2012; 51: 1150-59.
163. Kasari C, Patterson S. Interventions addressing social impairment in autism. Curr Psychiatry Rep 2012; 14: 713-25.
164. Kaale A, Smith L, Sponheim E. A randomized controlled trial of preschool-based joint attention intervention for children with autism. J Child Psychol Psychiatry 2012; 53: 97-105.
165. Kasari C, Paparella T, Freeman S, Jahromi LB. Language outcome in autism: randomized comparison of joint attention and play interventions. J Consult Clin Psychol 2008; 76: 125-37.
166. Landa RJ, Holman KC, ONeill AH, Stuart EA. Intervention targeting development of socially synchronous engagement in toddlers with autism spectrum disorder: a randomized controlled trial. J Child Psychol Psychiatry 2011; 52: 13-21.
167. Zimmer M, Desch L. Sensory integration therapies for children with developmental and behavioral disorders. Pediatrics 2012; 129: 1186-89.
168. Lang R, OReilly M, Healy O, et al. Sensory integration therapy for autism spectrum disorders: a systematic review. Res Autism Spectr Disord 2012; 6: 1004-18.
169. Farmer C, Thurm A, Grant P. Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 2013; 73: 303-14.
170. McPheeters ML, Warren Z, Sathe N, et al. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 2011; 127: e1312-21.
171. Mahajan R, Bernal MP, Panzer R, et al. Clinical practice pathways for evaluation and medication choice for attention-deficit/ hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics 2012; 130 (suppl 2): S125-38.
172. Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/ hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2012; 51: 733-41.
173. Anagnostou E, Hansen R. Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Curr Opin Pediatr 2011; 23: 621-27.
174. Akins RS, Angkustsiri K, Hansen RL. Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics 2010; 7: 307-19.
175. Krishnaswami S, McPheeters ML, Veenstra-Vanderweele J. A systematic review of secretin for children with autism spectrum disorders. Pediatrics 2011; 127: e1322-25.